An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis

Saved in:
Bibliographic Details
Published inOsteoarthritis and cartilage Vol. 28; pp. S376 - S377
Main Authors Simsek, I., Swearingen, C.J., Kennedy, S., Tambiah, J., Yazici, Y., Lane, N.E., Hochberg, M.C.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.04.2020
Subjects
Rheumatology
Online AccessGet full text

Cover

More Information
ISSN:1063-4584
DOI:10.1016/j.joca.2020.02.588